BridgeBio Oncology Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BridgeBio Oncology Therapeutics, Inc. has filed 170 SEC EDGAR filings since 20 Dec 2023

SEC filing history

Showing 51-75 of 170 matching filings.

Per page
25
Current page
3
4

4

Filing date
12 Dec 2025
Reporting date
10 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-94447

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-94447

SCHEDULE 13G/A filing

Filing date
13 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Oct 2025
Reporting date
10 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Oct 2025
Reporting date
02 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-289940

EFFECT filing

Filing date
10 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-289940

424B3

Filing date
10 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-289940

UPLOAD filing

Filing date
03 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-94447

SCHEDULE 13G filing

Filing date
03 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Aug 2025
Reporting date
26 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Aug 2025
Reporting date
26 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Aug 2025
Reporting date
26 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Aug 2025
Reporting date
26 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Aug 2025
Reporting date
26 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Aug 2025
Reporting date
26 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Aug 2025
Reporting date
26 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-288222

EFFECT filing

Filing date
19 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-94447

SCHEDULE 13G filing

Filing date
18 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-94447

SCHEDULE 13D filing

Filing date
18 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
18 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .